2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine

C109H141Br2N17O10 — CID 158170042

IUPAC2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine
SMILESCCCCN1CCOCC1.CNCCCN1CCOCC1.NCCCN1CCOCC1.N[C@H]1CCCc2ccccc21.Nc1ccc(N2CCCCC2)cc1-c1cc(C(=O)N[C@H]2CCCc3ccccc32)ccn1.O=C(N[C@H]1CCCc2ccccc21)c1ccnc(-c2cc(N3CCCCC3)ccc2[N+](=O)[O-])c1.O=C(N[C@H]1CCCc2ccccc21)c1ccnc(Br)c1.O=C(O)c1ccnc(Br)c1
InChIInChI=1S/C27H28N4O3.C27H30N4O.C16H15BrN2O.C10H13N.C8H18N2O.C8H17NO.C7H16N2O.C6H4BrNO2/c32-27(29-24-10-6-8-19-7-2-3-9-22(19)24)20-13-14-28-25(17-20)23-18-21(11-12-26(23)31(33)34)30-15-4-1-5-16-30;28-24-12-11-21(31-15-4-1-5-16-31)18-23(24)26-17-20(13-14-29-26)27(32)30-25-10-6-8-19-7-2-3-9-22(19)25;17-15-10-12(8-9-18-15)16(20)19-14-7-3-5-11-4-1-2-6-13(11)14;11-10-7-3-5-8-4-1-2-6-9(8)10;1-9-3-2-4-10-5-7-11-8-6-10;1-2-3-4-9-5-7-10-8-6-9;8-2-1-3-9-4-6-10-7-5-9;7-5-3-4(6(9)10)1-2-8-5/h2-3,7,9,11-14,17-18,24H,1,4-6,8,10,15-16H2,(H,29,32);2-3,7,9,11-14,17-18,25H,1,4-6,8,10,15-16,28H2,(H,30,32);1-2,4,6,8-10,14H,3,5,7H2,(H,19,20);1-2,4,6,10H,3,5,7,11H2;9H,2-8H2,1H3;2-8H2,1H3;1-8H2;1-3H,(H,9,10)/t24-;25-;14-;10-;;;;/m0000..../s1
InChIKeyFXIMEJUMFPTMCS-DCVVMIFDSA-N
MW2009.24 g/mol
LogP18.51
Rot. Bonds22

About 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine

2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine (PubChem CID 158170042) has the molecular formula C109H141Br2N17O10 and a molecular weight of 2009.24 g/mol. Its IUPAC name is 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine.

Molecular Properties

Compound Name2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine
PubChem CID158170042
Molecular FormulaC109H141Br2N17O10
Molecular Weight2009.24 g/mol
Exact Mass2005.94
IUPAC Name2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine
SMILESCCCCN1CCOCC1.CNCCCN1CCOCC1.NCCCN1CCOCC1.N[C@H]1CCCc2ccccc21.Nc1ccc(N2CCCCC2)cc1-c1cc(C(=O)N[C@H]2CCCc3ccccc32)ccn1.O=C(N[C@H]1CCCc2ccccc21)c1ccnc(-c2cc(N3CCCCC3)ccc2[N+](=O)[O-])c1.O=C(N[C@H]1CCCc2ccccc21)c1ccnc(Br)c1.O=C(O)c1ccnc(Br)c1
InChIInChI=1S/C27H28N4O3.C27H30N4O.C16H15BrN2O.C10H13N.C8H18N2O.C8H17NO.C7H16N2O.C6H4BrNO2/c32-27(29-24-10-6-8-19-7-2-3-9-22(19)24)20-13-14-28-25(17-20)23-18-21(11-12-26(23)31(33)34)30-15-4-1-5-16-30;28-24-12-11-21(31-15-4-1-5-16-31)18-23(24)26-17-20(13-14-29-26)27(32)30-25-10-6-8-19-7-2-3-9-22(19)25;17-15-10-12(8-9-18-15)16(20)19-14-7-3-5-11-4-1-2-6-13(11)14;11-10-7-3-5-8-4-1-2-6-9(8)10;1-9-3-2-4-10-5-7-11-8-6-10;1-2-3-4-9-5-7-10-8-6-9;8-2-1-3-9-4-6-10-7-5-9;7-5-3-4(6(9)10)1-2-8-5/h2-3,7,9,11-14,17-18,24H,1,4-6,8,10,15-16H2,(H,29,32);2-3,7,9,11-14,17-18,25H,1,4-6,8,10,15-16,28H2,(H,30,32);1-2,4,6,8-10,14H,3,5,7H2,(H,19,20);1-2,4,6,10H,3,5,7,11H2;9H,2-8H2,1H3;2-8H2,1H3;1-8H2;1-3H,(H,9,10)/t24-;25-;14-;10-;;;;/m0000..../s1
InChIKeyFXIMEJUMFPTMCS-DCVVMIFDSA-N
XLogP18.51
TPSA353.28 Ų
H-Bond Donors8
H-Bond Acceptors22
Rotatable Bonds22
Heavy Atoms138
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002009.24
LogP ≤ 518.51
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine?
The IUPAC name of 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine (CID 158170042) is 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine.
What is the SMILES notation for 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine?
The canonical SMILES for 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine is CCCCN1CCOCC1.CNCCCN1CCOCC1.NCCCN1CCOCC1.N[C@H]1CCCc2ccccc21.Nc1ccc(N2CCCCC2)cc1-c1cc(C(=O)N[C@H]2CCCc3ccccc32)ccn1.O=C(N[C@H]1CCCc2ccccc21)c1ccnc(-c2cc(N3CCCCC3)ccc2[N+](=O)[O-])c1.O=C(N[C@H]1CCCc2ccccc21)c1ccnc(Br)c1.O=C(O)c1ccnc(Br)c1.
What is the InChIKey of 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine?
The InChIKey is FXIMEJUMFPTMCS-DCVVMIFDSA-N. The full InChI is InChI=1S/C27H28N4O3.C27H30N4O.C16H15BrN2O.C10H13N.C8H18N2O.C8H17NO.C7H16N2O.C6H4BrNO2/c32-27(29-24-10-6-8-19-7-2-3-9-22(19)24)20-13-14-28-25(17-20)23-18-21(11-12-26(23)31(33)34)30-15-4-1-5-16-30;28-24-12-11-21(31-15-4-1-5-16-31)18-23(24)26-17-20(13-14-29-26)27(32)30-25-10-6-8-19-7-2-3-9-22(19)25;17-15-10-12(8-9-18-15)16(20)19-14-7-3-5-11-4-1-2-6-13(11)14;11-10-7-3-5-8-4-1-2-6-9(8)10;1-9-3-2-4-10-5-7-11-8-6-10;1-2-3-4-9-5-7-10-8-6-9;8-2-1-3-9-4-6-10-7-5-9;7-5-3-4(6(9)10)1-2-8-5/h2-3,7,9,11-14,17-18,24H,1,4-6,8,10,15-16H2,(H,29,32);2-3,7,9,11-14,17-18,25H,1,4-6,8,10,15-16,28H2,(H,30,32);1-2,4,6,8-10,14H,3,5,7H2,(H,19,20);1-2,4,6,10H,3,5,7,11H2;9H,2-8H2,1H3;2-8H2,1H3;1-8H2;1-3H,(H,9,10)/t24-;25-;14-;10-;;;;/m0000..../s1.
What are the key properties of 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine?
2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine has a molecular weight of 2009.24 g/mol, XLogP of 18.51, 22 rotatable bonds, 8 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(2-amino-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;2-bromopyridine-4-carboxylic acid;2-bromo-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;4-butylmorpholine;N-methyl-3-morpholin-4-ylpropan-1-amine;3-morpholin-4-ylpropan-1-amine;2-(2-nitro-5-piperidin-1-ylphenyl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]pyridine-4-carboxamide;(1S)-1,2,3,4-tetrahydronaphthalen-1-amine is sourced from PubChem (CID 158170042), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).